Vertex nonopioid painkiller posts positive midstage trial results
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019.Brian Snyder | ReutersShares of Vertex Pharmaceuticals jumped Wednesday after the company's painkiller, which is being tested as an alternative to opioids, significantly decreased pain in a midstage trial.Those positive results for...